- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.09. | Magle Chemoswed Holding AB: Magle Group Completes Restructuring Of Its Outstanding Debt And Capital Structure | 175 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") announces that it has completed the restructuring of its outstanding debt and capital structure (the "Restructuring") as previously... ► Artikel lesen | |
| MAGLE CHEMOSWED Aktie jetzt für 0€ handeln | |||||
| 10.09. | Magle Chemoswed Holding AB: Magle Chemoswed Holding AB (publ) appoints Aaron Wong as Chief Executive Officer | 204 | GlobeNewswire (Europe) | The Board of Directors of Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") has today appointed Aaron Wong as Chief Executive Officer of the Company on a permanent basis, effective... ► Artikel lesen | |
| 02.09. | Magle Chemoswed Holding AB: Magle Chemoswed Holding AB (publ) initiates implementation of restructuring following successful written procedure | 180 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), org. no. 556913-4710 (the "Company"), today on 2 September 2026 announces that it will initiate the implementation of the contemplated amendments and waivers as set... ► Artikel lesen | |
| 26.08. | Magle Chemoswed Holding AB: Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) | 160 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), org. no. 556913-4710 (the "Company"), held today, on 26 August 2026, an extraordinary general meeting (the "EGM") at the Company's premises at Agneslundsvägen 20B... ► Artikel lesen | |
| 17.08. | Decision by the Disciplinary Committee regarding Magle Chemoswed Holding AB | 280 | GlobeNewswire | Stockholm, August 17, 2026 - The Disciplinary Committee of Nasdaq Stockholm (the "Exchange") has found that Magle Chemoswed Holding AB (the "Company") has breached the rules of Nasdaq First North... ► Artikel lesen | |
| 12.08. | Magle Chemoswed Holding AB: Magle Chemoswed Holding Reports Financial Results For Second Quarter 2026 | 135 | GlobeNewswire (Europe) | Early signs of stabilisation in a year of transition
Q2 2026 KEY INDICATORS (Apr-Jun)Total revenue amounted to 74.6 MSEK (55.2)EBITDA equalled 1.5 MSEK (-20.6)Operating profit (EBIT) was -13.1 MSEK... ► Artikel lesen | |
| 27.07. | The observation status for Magle Chemoswed Holding AB is updated | 262 | GlobeNewswire | On June 9, 2026, the shares in Magle Chemoswed Holding AB (the "Company") were given observation status with reference to uncertainty in respect of the issuer's financial position.
Today, July... ► Artikel lesen | |
| 27.07. | Magle Chemoswed Holding AB: The board of Magle Chemoswed Holding AB (publ) proposes that the EGM resolves on voluntary delisting of the company's shares from Nasdaq First North Growth Market | 280 | GlobeNewswire (Europe) | The board of directors of Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), has today resolved to propose that an extraordinary general meeting resolves on the delisting of the... ► Artikel lesen | |
| 10.07. | Magle Chemoswed Holding AB: Magle Group Has Resolved On A Restructuring Of Its Outstanding Debt And Capital Structure, Including Debt-for-equity Swap, Issuance Of Super Senior Bonds And Directed Share Issues | 527 | GlobeNewswire (Europe) | As previously announced, Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") has for some time been in constructive negotiations with bondholders representing approximately 79 per cent... ► Artikel lesen | |
| 30.06. | Magle Chemoswed Holding AB: Bulletin from the Annual General Meeting in Magle Chemoswed Holding AB (publ) | 225 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), today, on 30 June 2026, held its Annual General Meeting at the Company's premises at Agneslundsvägen 20B in Malmö. The following... ► Artikel lesen | |
| 25.06. | Magle Chemoswed Holding AB: Magle Group announces deferral of interest payment in respect of its bonds, and update to timing of intended financial restructuring | 266 | GlobeNewswire (Europe) | As communicated by Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") on 11 June 2026, the Company received a proposal from an ad hoc group of bondholders (the "Ad Hoc Group") in respect... ► Artikel lesen | |
| 09.06. | Magle Chemoswed Holding AB receives observation status | 223 | GlobeNewswire | On June 7, 2026, Magle Chemoswed Holding AB (the "Company") disclosed a press release with an update regarding the Company's financing arrangements.
According to item 6.1.3 (b) (iv) of the Nasdaq... ► Artikel lesen | |
| 07.06. | Magle Chemoswed Holding AB: Magle Chemoswed Holding AB - Update on Financing Arrangements and Ongoing Stakeholder Discussions | 292 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ) ("Magle" or the "Company") provides an update regarding its financing arrangements and ongoing discussions with key stakeholders.
Danske Bank Facility Maturing on 30... ► Artikel lesen | |
| 31.05. | Magle Chemoswed Holding AB: Magle Chemoswed Holding Reports Financial Results For First Quarter 2026 | 266 | GlobeNewswire (Europe) | A difficult quarter in a year of necessary change
Q1 2026 KEY INDICATORSTotal revenue amounted to 71.7 MSEK (85.1)EBITDA equalled -6.6 MSEK (12.8)Operating profit (EBIT) was -17.8 MSEK (2.1)Profit after... ► Artikel lesen | |
| 26.05. | Magle Chemoswed Holding AB: Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) | 320 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), today, on 26 May 2026, held an Extraordinary General Meeting (the "EGM") at the Company's premises at Agneslundsvägen 20B in... ► Artikel lesen | |
| 12.05. | New last trading day for paid subscription shares (BTA) of Magle Chemoswed Holding AB | 299 | GlobeNewswire | At the request of Magle Chemoswed Holding AB, the last trading day in Magle Chemoswed Holding AB's paid subscription shares will be changed from 2026-05-20 to 2026-05-13.
Instrument:
Paid subscription... ► Artikel lesen | |
| 30.04. | Magle Chemoswed Holding AB: Magle Group Announces Outcome of Rights Issue | 306 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 14.04. | Magle Chemoswed Holding AB: Magle Group Publishes Information Document in Connection with Upcoming Rights Issue | 340 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 13.04. | XFRA CAPITAL ADJUSTMENT INFORMATION - 13.04.2026 | 237 | Xetra Newsboard | Das Instrument LUR SE0015192075 LUXBRIGHT AB EQUITY wird ex Kapitalmassnahme gehandelt am 13.04.2026 The instrument LUR SE0015192075 LUXBRIGHT AB EQUITY is traded ex capital adjustment on 13.04.2026Das... ► Artikel lesen | |
| 10.04. | Magle Chemoswed Holding AB: Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) | 244 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), today, on 10 April 2026, held an Extraordinary General Meeting (the "EGM") at the Company's premises at Agneslundsvägen 20B in... ► Artikel lesen |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 44,940 | -1,01 % | 90 Milliarden US-Dollar bis 2030: Wie Bayer, Mesoblast und NurExone regenerative Medizin unterschiedlich entwickeln | ||
| MERCK KGAA | 136,90 | +1,82 % | Merck Aktie | Wichtige Durchschnittslinien durchbrochen | Analyse | ||
| NOVO NORDISK | 33,210 | -0,48 % | Novo Nordisk gerät trotz GLP-1 unter Druck - warum Eli Lilly und Co. schon Milliarden in neue Plattformen investieren | ||
| ETON PHARMACEUTICALS | 55,42 | 0,00 % | Eton Pharmaceuticals, Inc. - 8-K, Current Report | ||
| SANOFI | 71,08 | -0,03 % | Laufende Fusionskontrollverfahren: Sanofi, Paris/FR; Erwerb eines Minderheitsanteils an der Cheplapharm SE (Gemeinschaftsunternehmen mit der Braun Invest Holding GmbH, Greifswald) | Datum der Anmeldung:24.09.2026Aktenzeichen:B3-102/26Unternehmen:Sanofi, Paris/FR; Erwerb eines Minderheitsanteils an der Cheplapharm SE (Gemeinschaftsunternehmen mit der Braun Invest Holding GmbH, Greifswald)Produktmärkte:Arzneimittel... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 13,685 | -0,04 % | Generate Biomedicines, Inc.: Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of 'Armored' CAR T Therapy for Ovarian Cancer | Engineered with AI to optimize T-cell function in solid tumors, GB-5267 is the first next-generation cell therapy for ovarian cancer to enter clinical trials First patient treated in new clinical... ► Artikel lesen | |
| SEAPORT THERAPEUTICS | 18,420 | 0,00 % | Seaport Therapeutics Prices Upsized IPO Of 14.16 Mln Shares At $18 Each | WASHINGTON (dpa-AFX) - Seaport Therapeutics, Inc. (SPTX) said it has priced its upsized initial public offering of 14.16 shares at $18 per share, at the top of the target range. The company... ► Artikel lesen | |
| PFIZER | 24,735 | +0,18 % | Litfulo and tilrekimig data bolster Pfizer's immunology plans | ||
| LB PHARMACEUTICALS | 37,080 | +0,24 % | Needham initiates LB Pharmaceuticals stock with buy rating | ||
| ELI LILLY | 1.019,20 | +0,33 % | Eli Lilly's Jaypirca gains additional indication for untreated leukemia, lymphoma | ||
| BIOHAVEN | 12,870 | 0,00 % | Biohaven Ltd.: Biohaven's Clinical Data on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload, Selected for Oral Presentation at the EORTC-NCI-AACR Symposium 2026 | Oral presentation selected: Phase 1 findings from the ongoing BHV1530-101 study will be featured in an oral presentation at the 38th EORTC-NCI-AACR Symposium on... ► Artikel lesen | |
| SCHOTT PHARMA | 24,550 | +0,82 % | Aktien Frankfurt: Dax macht Verluste wett - Ölpreis und Anleiherenditen im Fokus | FRANKFURT (dpa-AFX) - Der deutsche Aktienmarkt hat sich am Dienstagnachmittag von seinen Anfangsverlusten vollständig erholt. Eine leichte Entspannung bei den Ölpreisen und bei den Anleiherenditen... ► Artikel lesen | |
| NOVARTIS | 124,98 | -0,14 % | CH-Verlauf: Fester dank Novartis und Nestlé, Roche fallen ab | Zürich - Der Schweizer Aktienmarkt ist mit Schwung in die neue Woche gestartet und hat die Marke bei 14'000 klar zurückerobert. In der Folge konnte er indes dieses Niveau nicht ganz halten. Gestützt... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,555 | +0,11 % | Aquestive appoints Rich Daly to board of directors | ||
| GILEAD SCIENCES | 128,68 | +0,09 % | Assembly Biosciences: Herpes-Countdown mit Gilead |
Das Unternehmen MAGLE CHEMOSWED HOLDING AB kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,006 (-22,64 %) liegt der Kurs bei 0,021 Euro. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MAGLE CHEMOSWED HOLDING AB finden Sie auf Wallstreet Online.